Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Wave Life Sciences Partners with GSK to Advance Hepatology Candidate, Triggering $12 Million Milestone Payment.
Wave Life Sciences announces that GSK has selected a candidate for development from their SpiNA siRNA collaboration, leading to a $12 million milestone payment. The partnership also holds the potential for Wave to earn up to $375 million in additional milestone payments and tiered royalties.
Company Information
Company
Wave Life Sciences
Location
Cambridge, Massachusetts, United States
About
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
CambridgeBiotechnologyHealthcareHealth CareMedicalTherapeutics